Skip to main content

Table 3 Results of measures of diagnostic performance (sensitivity and specificity) for each group studied based on the manufacturer’s recommendations of serological tests

From: Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan®, ID Screen® and Leishmania 96®), a rapid test (Speed Leish K®) and an in-house IFAT

Groups Measures ID screen® Leiscan® Leishmania 96® IFAT Speed Leish K®
Clinically sick infected dogs (n = 36) Sensitivity 0.972 0.972 0.972 1.000 0.917
Clinically healthy infected dogs (n = 18) 0.833 0.667 0.611 0.944 0.167
Seropositive infected dogs High antibody levels (n = 34) 1.000 1.000 1.000 0.882 0.853
Medium antibody levels (n = 14) 1.000 1.000 1.000 0.357 0.214
Low antibody levels (n = 5) 0.800 0.800 1.000 1.000 0.000
Total (n = 53) 0.981 0.981 1.000 0.750 0.604
Uninfected dogs from non-endemic area (n = 50) Specificity 1.000 1.000 1.000 0.940 1.000
Uninfected dogs from endemic areas (n = 32) 1.000 1.000 0.875 0.938 1.000
Dogs seropositive to other pathogens (n = 14) 1.000 1.000 0.571 0.786 1.000